Holzer & Holzer, LLC has issued reminders for investors to meet deadlines to seek lead plaintiff status in shareholder class action lawsuits against Aquestive Therapeutics, Nektar Therapeutics, and Eos Energy Enterprises. These lawsuits allege misleading statements or failure to disclose material facts related to drug applications, clinical trials, and production capacity between 2025 and 2026. Investors who purchased shares during the specified periods and suffered losses are encouraged to contact the law firm before the May 4-5, 2026 deadlines to protect their rights. This is a key step for shareholders aiming to participate actively in these legal actions and potentially recover losses.
Eos Energy Enterprises secured a multi-million-dollar contract with the US Department of War to provide zinc-based long-duration energy storage systems for the Golden Dome missile defense initiative. The technology, manufactured in Pittsburgh, aims t...
Eos Energy Enterprises announced preliminary Q2 2026 results, expecting record quarterly revenue between $68 million and $69 million, driven by a threefold increase in shipments. The company expanded manufacturing capacity with a second battery produ...
Frontier Power USA (FPUSA) has selected the Wildfire BESS Project, a 100 MW / 400 MWh battery energy storage system in Texas, advancing its strategic partnership with Bimergen Energy and Eos Energy Enterprises. This selection brings FPUSA's closed an...
